vs
Side-by-side financial comparison of ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) and Alpine Income Property Trust, Inc. (PINE). Click either name above to swap in a different company.
ASCENTAGE PHARMA GROUP INTERNATIONAL is the larger business by last-quarter revenue ($32.6M vs $18.4M, roughly 1.8× Alpine Income Property Trust, Inc.).
Ascentage Pharma Group International is a global clinical-stage biotechnology company specializing in developing novel targeted therapies for cancers, chronic viral infections, and age-related diseases. It focuses on small molecule drugs targeting apoptosis pathways and other key oncogenic mechanisms, with operations spanning China, the U.S., and other global markets, serving patients with unmet medical needs worldwide.
Alpine Income Property Trust, Inc. is a publicly traded real estate investment trust that owns and operates a diversified portfolio of single-tenant net lease commercial properties across the United States. Its core asset segments include essential retail, industrial, and suburban office spaces, delivering stable recurring rental revenue to support consistent returns for its shareholders.
AAPG vs PINE — Head-to-Head
Income Statement — Q2 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $32.6M | $18.4M |
| Net Profit | $11.4M | $2.2M |
| Gross Margin | 90.7% | — |
| Operating Margin | — | 35.4% |
| Net Margin | — | 11.9% |
| Revenue YoY | — | 29.6% |
| Net Profit YoY | — | 285.3% |
| EPS (diluted) | — | $0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $18.4M | ||
| Q4 25 | — | $16.9M | ||
| Q3 25 | — | $14.6M | ||
| Q2 25 | $32.6M | $14.9M | ||
| Q1 25 | — | $14.2M | ||
| Q4 24 | — | $13.8M | ||
| Q3 24 | — | $13.5M | ||
| Q2 24 | — | $12.5M |
| Q1 26 | — | $2.2M | ||
| Q4 25 | — | $1.5M | ||
| Q3 25 | — | $-1.3M | ||
| Q2 25 | $11.4M | $-1.6M | ||
| Q1 25 | — | $-1.2M | ||
| Q4 24 | — | $-958.0K | ||
| Q3 24 | — | $3.1M | ||
| Q2 24 | — | $204.0K |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 90.7% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | 35.4% | ||
| Q4 25 | — | 35.3% | ||
| Q3 25 | — | 16.6% | ||
| Q2 25 | — | 16.8% | ||
| Q1 25 | — | 16.0% | ||
| Q4 24 | — | 14.3% | ||
| Q3 24 | — | 47.9% | ||
| Q2 24 | — | 24.0% |
| Q1 26 | — | 11.9% | ||
| Q4 25 | — | 8.7% | ||
| Q3 25 | — | -9.0% | ||
| Q2 25 | — | -11.0% | ||
| Q1 25 | — | -8.3% | ||
| Q4 24 | — | -6.9% | ||
| Q3 24 | — | 22.8% | ||
| Q2 24 | — | 1.6% |
| Q1 26 | — | $0.06 | ||
| Q4 25 | — | $0.07 | ||
| Q3 25 | — | $-0.09 | ||
| Q2 25 | — | $-0.12 | ||
| Q1 25 | — | $-0.08 | ||
| Q4 24 | — | $-0.06 | ||
| Q3 24 | — | $0.21 | ||
| Q2 24 | — | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $2.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $312.5M |
| Total Assets | — | $745.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $2.6M | ||
| Q4 25 | — | $4.6M | ||
| Q3 25 | — | $1.2M | ||
| Q2 25 | — | $5.0M | ||
| Q1 25 | — | $6.1M | ||
| Q4 24 | — | $1.6M | ||
| Q3 24 | — | $2.6M | ||
| Q2 24 | — | $3.3M |
| Q1 26 | — | — | ||
| Q4 25 | — | $377.7M | ||
| Q3 25 | — | $358.2M | ||
| Q2 25 | — | $352.6M | ||
| Q1 25 | — | $356.5M | ||
| Q4 24 | — | $301.5M | ||
| Q3 24 | — | $278.9M | ||
| Q2 24 | — | $268.3M |
| Q1 26 | — | $312.5M | ||
| Q4 25 | — | $279.9M | ||
| Q3 25 | — | $223.5M | ||
| Q2 25 | — | $229.8M | ||
| Q1 25 | — | $240.9M | ||
| Q4 24 | — | $253.0M | ||
| Q3 24 | — | $248.2M | ||
| Q2 24 | — | $244.0M |
| Q1 26 | — | $745.1M | ||
| Q4 25 | — | $715.9M | ||
| Q3 25 | — | $621.4M | ||
| Q2 25 | — | $628.4M | ||
| Q1 25 | — | $647.4M | ||
| Q4 24 | — | $605.0M | ||
| Q3 24 | — | $579.0M | ||
| Q2 24 | — | $565.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.35× | ||
| Q3 25 | — | 1.60× | ||
| Q2 25 | — | 1.53× | ||
| Q1 25 | — | 1.48× | ||
| Q4 24 | — | 1.19× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AAPG
| Products | $29.7M | 91% |
| Others | $2.9M | 9% |
PINE
| Lease Income | $12.6M | 68% |
| Other | $5.8M | 31% |
| Other Revenue | $46.0K | 0% |
